Latest & greatest articles for overdiagnosis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on overdiagnosis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on overdiagnosis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for overdiagnosis

1. Overdiagnosis: what it is and what it isn?t Full Text available with Trip Pro

Overdiagnosis: what it is and what it isn?t Overdiagnosis: what it is and what it isn’t | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Overdiagnosis: what it is and what it isn’t Article Text Editorial Overdiagnosis: what it is and what it isn’t Free John Brodersen , , Lisa M Schwartz , Carl Heneghan , Jack William O’Sullivan , Jeffrey K Aronson , Steven Woloshin Statistics from Altmetric.com Why then, can one desire too much

2018 Evidence-Based Medicine

2. Overdiagnosis

Overdiagnosis Top results for overdiagnosis - Trip Database or use your Google+ account Turning Research Into Practice ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2 (...) ) and (#3 or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for overdiagnosis The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms

2018 Trip Latest and Greatest

3. Overdiagnosis from mammography screening

Overdiagnosis from mammography screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) Breast and Ovarian Cancer Centre* first released a position statement on overdiagnosis from mammographic screening in 2008, followed by an update in 2010. The present statement is a further update by Cancer Australia. This update was based on a review of the published scientific literature and incorporation of input from international and national experts in the field. Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing

2014 Cancer Australia

4. A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month

A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month | ScienceBlogs Advertisment Search Search Toggle navigation Main navigation A study of overdiagnosis due to mammography reported during Breast Cancer Awareness Month By on October 13, 2016. I knew it. I just knew it. I knew I couldn’t get through October, a.k.a. Breast Cancer Awareness Month, without a controversial (...) mammography study to sink my teeth into. And I didn’t. I suppose I should just be used to this now. I’m referring to the latest opus from H. Gilbert Welch and colleagues that appeared in the New England Journal of Medicine last night, . Yes, it’s about overdiagnosis, something I’ve blogged about more times than I can remember now, but it’s actually a rather interesting take on the issue. Before 2008 or so, I never gave that much thought to the utility of mammographic screening as a means of early

2016 Respectful Insolence

5. Primary care: Overdiagnosis paradigm: not suitable for decreasing the overuse of antibiotics Full Text available with Trip Pro

Primary care: Overdiagnosis paradigm: not suitable for decreasing the overuse of antibiotics Overdiagnosis paradigm: not suitable for decreasing the overuse of antibiotics | BMJ Evidence-Based Medicine Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? You are here Overdiagnosis paradigm: not suitable for decreasing the overuse of antibiotics Article Text EBM analysis Primary care Overdiagnosis paradigm: not suitable for decreasing the overuse of antibiotics Gloria Cordoba , Carl Llor . Statistics from Altmetric.com Introduction Unnecessary and excessive use of antibiotics is the main driver of antimicrobial resistance. The prospect of patients dying from common infections caused

2019 Evidence-Based Medicine

6. Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach. Full Text available with Trip Pro

Lifetime risk of prostate cancer overdiagnosis in Australia: quantifying the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach. To quantify the risk of overdiagnosis associated with prostate cancer screening in Australia using a novel lifetime risk approach.Modelling and validation of the lifetime risk method using publicly available population data.Opportunistic screening for prostate cancer in the Australian population.Australian (...) male population (1982-2012).Prostate-specific antigen testing for prostate cancer screening.Primary: lifetime risk of overdiagnosis in 2012 (excess lifetime cancer risk adjusted for changing competing mortality); Secondary: lifetime risk of prostate cancer diagnosis (unadjusted and adjusted for competing mortality); Excess lifetime risk of prostate cancer diagnosis (for all years subsequent to 1982).The lifetime risk of being diagnosed with prostate cancer increased from 6.1% in 1982 (1 in 17

2019 BMJ open

7. Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment? Full Text available with Trip Pro

Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment? Screening for prostate cancer is frequent in high-income countries, including Switzerland. Notably due to overdiagnosis and overtreatment, various organisations have recently recommended against routine screening, potentially having an impact on incidence, mortality, and surgery rates. Our aim was therefore to examine whether secular trends in the incidence and mortality (...) and prostatectomy observed in Switzerland among men younger than 70 years have concomitantly leveled off around 2002/2003. Given the decreasing mortality, these trends may reflect recent changes in screening and clinical workup practices, with a possible attenuation of overdiagnosis and overtreatment.

2019 PLoS ONE

8. Overdiagnosis and lives saved due to reflex testing men with intermediate prostate-specific antigen levels. Full Text available with Trip Pro

Overdiagnosis and lives saved due to reflex testing men with intermediate prostate-specific antigen levels. Several prostate cancer early detection biomarkers are available for reflex testing in men with intermediate prostate-specific antigen (PSA) levels. Studies of these biomarkers typically provide information about diagnostic performance but not about overdiagnosis and lives saved, the primary drivers of associated harm and benefit.We projected overdiagnoses and lives saved using

2019 Journal of the National Cancer Institute

9. On the Social Construction of Overdiagnosis: Comment on "Medicalisation and Overdiagnosis: What Society Does to Medicine" Full Text available with Trip Pro

On the Social Construction of Overdiagnosis: Comment on "Medicalisation and Overdiagnosis: What Society Does to Medicine" In an interesting article Wieteke van Dijk and colleagues argue that societal developments and values influence the practice of medicine, and thus can result in both medicalisation and overdiagnosis. They provide a convincing argument that overdiagnosis emerges in a social context and that it has socially constructed implications. However, they fail to show (...) that overdiagnosis per se is socially constructed and how this construction occurs. Moreover, the authors discuss overdiagnosis on a micro level without acknowledging that overdiagnosis cannot be observed in individuals "in the doctor's office." We cannot tell whether a diagnosed person is overdiagnosed or not. This is the core of the problem. Despite these shortcomings, Wieteke van Dijk and her colleagues are certainly on to something important, and they should be encouraged to elaborate their perspective. We

2017 International journal of health policy and management

10. Overdiagnosis from mammographic screening

Overdiagnosis from mammographic screening Overdiagnosis from mammographic screening | Cancer Australia ") //--> ") //--> Search form Search You are here » » Revised & updated: 2014 , 2010 Published: 2008 This position statement has been endorsed by the Australian Health Ministers’ Advisory Council Standing Committee on Screening, Cancer Council Australia and the Royal Australian and New Zealand College of Radiologists, and is supported by the Cancer Australia Advisory Council. Context National (...) Breast and Ovarian Cancer Centre* first released a position statement on overdiagnosis from mammographic screening in 2008, followed by an update in 2010. The present statement is a further update by Cancer Australia. This update was based on a review of the published scientific literature and incorporation of input from international and national experts in the field. Cancer Australia position statements address significant clinical issues, emerging issues in cancer control and issues of ongoing

2014 MHRA Drug Safety Update

11. Overdiagnosis and overtreatment: generalists — it’s time for a grassroots revolution Full Text available with Trip Pro

Overdiagnosis and overtreatment: generalists — it’s time for a grassroots revolution 26917633 2017 05 19 2018 11 13 1478-5242 66 644 2016 Mar The British journal of general practice : the journal of the Royal College of General Practitioners Br J Gen Pract Overdiagnosis and overtreatment: generalists--it's time for a grassroots revolution. 116-7 10.3399/bjgp16X683881 Treadwell Julian J Hindon Surgery, Wiltshire; Vice-Chair, RCGP Standing Group on Overdiagnosis; Editorial Board Member, Drugs (...) and Therapeutics Bulletin; GP Appraiser, NHSE South Central. McCartney Margaret M Fulton Street Medical Centre, Glasgow; Chair, RCGP Standing Group on Overdiagnosis. eng Editorial England Br J Gen Pract 9005323 0960-1643 IM General Practice standards Humans Medical Overuse prevention & control statistics & numerical data Practice Guidelines as Topic Practice Patterns, Physicians' statistics & numerical data United Kingdom 2017 03 01 2016 2 27 6 0 2016 2 27 6 0 2017 5 20 6 0 ppublish 26917633 66/644/116 10.3399

2016 The British Journal of General Practice

12. How do patients and the public understand overtesting and overdiagnosis? A protocol for a thematic meta-synthesis of qualitative research. Full Text available with Trip Pro

How do patients and the public understand overtesting and overdiagnosis? A protocol for a thematic meta-synthesis of qualitative research. Examining patient and public understanding of overtesting and overdiagnosis (OverTD) is vital for reducing the burden of OverTD. Studies from disparate contexts, disciplines and focusing on disparate healthcare issues have examined patient and public understanding of OverTD. A synthesis is needed to bring this literature together, examine common themes

2020 BMJ open

13. Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Full Text available with Trip Pro

Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn’t’ Article Text Letter Response to Brodersen et al’ s ‘Overdiagnosis: what it is and what it isn ’ t ’ Wendy A Rogers 1 , 2 , Yishai Mintzker 3 Statistics from

2018 Evidence-Based Medicine

14. Lyme Disease Overdiagnosis in a Large Healthcare System: A Population-based, Retrospective Study. Full Text available with Trip Pro

Lyme Disease Overdiagnosis in a Large Healthcare System: A Population-based, Retrospective Study. To evaluate the impact of false positive IgM immunoblots on Lyme disease treatment and case reporting in a large healthcare system.We obtained results of all Lyme disease serologic tests ordered at U.S. Air Force healthcare facilities in the United States between January 2013 and December 2017. We conducted chart reviews to adjudicate positive IgM immunoblots (from two-tier and independent testing

2019 Clinical Microbiology and Infection

15. THESIS: Preventing Overdiagnosis, the Quaternary Prevention

THESIS: Preventing Overdiagnosis, the Quaternary Prevention THESIS: Preventing Overdiagnosis, the Quaternary Prevention — Less is More Medicine Discover Act About Nanaimo BC Phone Number Putting the focus on effective, appropriate, and good-value healthcare Your Custom Text Here March 20, 2018 Maria Llargués Pou, a soon-to-be Family Physician in Barcelona, recently shared with me her Bachelor's Thesis. Her work - "Primum non nocere " Preventing Overdiagnosis, the Quaternary Prevention provides (...) , contemporary efforts to tackle overdiagnosis, like the Choosing Wisely Campaign and Preventing Overdiagnosis conference. Her paper serves as a great "backgrounder" for those who wish to learn more about the broad themes and history of this movement. You can view the full text In , , Tags , , , , , , , articles and Original Commentary on the topic of "Less is More in Medicine" and The "Right Care" SITE SEARCH: SUBSCRIBE: E-mail updates: SIMILAR BLOGS: (ES) (not affiliated) (BP) CATEGORIES: TWEETS: TIME OUT

2018 Less is More in Medicine Blog

16. Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis. Full Text available with Trip Pro

Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis. To describe the lived experience of a possible prostate cancer overdiagnosis in men who resisted recommended treatment.Qualitative interview study SETTING: Australia PARTICIPANTS: 11 men (aged 59-78 years) who resisted recommended prostate cancer treatment because of concerns about overdiagnosis and overtreatment.Reported experience of screening, diagnosis and treatment (...) through treatment decision making. This often led them to develop a sense of disillusionment and distrust towards the medical profession and conventional medicine. The findings show how some men who were told they would soon die without treatment (a prognosis which ultimately did not eventuate) reconciled issues of overdiagnosis and potential overtreatment with their own diagnosis and situation over the ensuing 1 to 20+ years.Men who choose not to have recommended treatment for prostate cancer may

2019 BMJ open

17. Personalized risks of overdiagnosis for screen-detected prostate cancer incorporating patient comorbidities: Estimation and communication. Full Text available with Trip Pro

Personalized risks of overdiagnosis for screen-detected prostate cancer incorporating patient comorbidities: Estimation and communication. Shared patient-physician decision-making regarding treatment for prostate cancer detected by prostate-specific antigen screening involves a complex calculus weighing the risk of the cancer and patient life expectancy. We investigated quantifying these competing risks using the probability that the cancer was "overdiagnosed"-i.e., would not have been (...) clinically diagnosed (diagnosed without screening) during the patient's remaining lifetime.Using an established model of prostate cancer screening and clinical diagnosis, we simulated screen-detected cases and determined whether modeled clinical diagnosis would occur before non-cancer death, which was based on comorbidity-adjusted population lifetables. Logistic regression models were fitted to the simulated data and used to estimate overdiagnosis probabilities given patient age, PSA level, Gleason sum

2019 Journal of Urology

18. Reducing overdiagnosis in primary care is needed Full Text available with Trip Pro

Reducing overdiagnosis in primary care is needed 28914565 2018 10 18 2018 11 13 1751-1402 23 1 2017 12 The European journal of general practice Eur J Gen Pract Reducing overdiagnosis in primary care is needed. 215-216 10.1080/13814788.2017.1365836 Llor Carl C a Via Roma Primary Healthcare Centre , Barcelona , Spain. eng Editorial England Eur J Gen Pract 9513566 1381-4788 IM Humans Medical Overuse prevention & control Primary Health Care 2017 9 16 6 0 2017 9 16 6 0 2018 10 20 6 0 ppublish

2017 The European journal of general practice

19. Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates. Full Text available with Trip Pro

Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates. The degree of overdiagnosis due to lung cancer screening in the general US population remains unknown. Estimates may be influenced by the method used and by decreasing smoking trends, which reduce lung cancer risk and screening eligibility over time. Therefore, we aimed to estimate the degree of overdiagnosis due to lung cancer screening in the general US population, using three distinct methods.The MISCAN-Lung (...) model was used to project lung cancer incidence and overdiagnosis in the general US population between 2018-2040, assuming perfect adherence to the United States Preventive Task Force recommendations. MISCAN-Lung was calibrated to the NLST and PLCO trials and incorporates birth-cohort-specific smoking trends and life expectancies. We estimated overdiagnosis using the cumulative excess-incidence approach, the annual excess-incidence approach, and the microsimulation approach.Using the cumulative

2020 Lung Cancer

20. Inequivalence of non-aggressiveness in clinically diagnosed lung cancers and overdiagnosis in lung cancer screening trials Full Text available with Trip Pro

Inequivalence of non-aggressiveness in clinically diagnosed lung cancers and overdiagnosis in lung cancer screening trials 29708141 2018 11 14 2072-1439 10 3 2018 Mar Journal of thoracic disease J Thorac Dis Inequivalence of non-aggressiveness in clinically diagnosed lung cancers and overdiagnosis in lung cancer screening trials. 1230-1232 10.21037/jtd.2018.01.164 Reich Jerome M JM Thoracic Oncology Program, Earle A Chiles Research Institute, Portland, OR, USA. Kim Jong S JS Department

2018 Journal of thoracic disease